How many years India’s biotech curriculum trails its factories. Eight technologies, the delay on each, who is quietly paying ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

Adam Feuerstein is a senior writer and biotech columnist, reporting on the crossroads of drug development, business, Wall Street, and biotechnology. He is also a co-host of the weekly biotech podcast ...

Enveda, a privately held AI biotechnology startup, has doubled its valuation to about $2 billion as momentum builds behind tech-driven approaches to discovering new medicines. The financing will help ...

Heard on the Street columnist David Wainer joins co-hosts Telis Demos and Miriam Gottfried on WSJ’s Take On the Week to break down how investors should navigate this year’s rally in biotech and pharma ...

The latest company to spin out of a Stanford Medicine lab is a biotech undertaking with 37,000 employees—and none of them are human. There's no lab space, no lunch breaks and no payroll. It's an ...

Investors on the libertarian fringe of the biotech industry are making their dream of widespread access to experimental drugs a reality in Montana. Last year, they helped draft a state law to expand ...

They’re designing viruses, reversing the aging process, and saving lives. Every year, MIT Technology Review puts together a list of some of the brightest and best young minds working across science ...

"It is a privilege to join Legend Biotech at ⁠an important moment in the company's growth," Zhang, who spent 15 years at Novartis, said in a statement. Zhang succeeds Ying Huang, who resigned in July ...

Ingrid Zhang joined Legend after a 15-year tenure at Novartis, most recently serving as chief commercial officer for Novartis’ ex-U.S. international business. (Legend Biotech) Legend Biotech has found ...